03320 CHINARES PHARMA
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.41X | Oper Margin | 5.0% |
|---|---|---|---|
| LT Debt/Equity | 49.0% | Net Margin | 1.3% |
| Total Debt/Equity | 143.0% | Return on Equity | 6.9% |
| Price/Book | 0.60X | Return on Assets | 1.3% |
| (HKD 4.890) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 3,542.81 | 4,248.15 | 3,924.50 | 3,768.89 | 3,297.13 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -16.6 | +8.3 | +4.1 | +14.3 | +0.3 |
| Earnings Per Share (HKD) | 0.564 | 0.676 | 0.625 | 0.6 | 0.525 |
| Earnings Per Share Growth (%) | -16.6 | +8.2 | +16.8 | +14.3 | +0.4 |
| Dividend Per Share (HKD) | 0.146 | 0.170 | 0.160 | 0.150 | 0.120 |
| P/E* (X) | 8.67 | 7.23 | 7.83 | 8.15 | 9.32 |
| Yield (%) | 2.99 | 3.47 | 3.27 | 3.07 | 2.45 |
| Dividend Share (%) | 25.91 | 25.10 | 25.61 | 25.00 | 22.87 |
| Book NAV (HKD) | 8.167 | 8.063 | 7.773 | 8.115 | 7.396 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-07 21:40:22
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 131,867 | 128,598 | +2.5 | 126,805 |
| Operating Result | 6,298 | 6,849 | -8.0 | 6,273 |
| Associates | 113.236 | 198.77 | -43.0 | 219.473 |
| Profit Before Taxation | 6,416 | 7,046 | -8.9 | 6,495 |
| Taxation | 1,362 | 1,506 | -9.6 | 1,299 |
| Profit /( Loss) After Taxation | 5,054 | 5,541 | -8.8 | 5,196 |
| Minority Interests | 2,976 | 2,936 | +1.4 | 2,423 |
| Net Profit | 2,073 | 2,605 | -20.4 | 2,773 |
| Earnings Per Share () | 0.3616 | 0.4456 | -18.9 | 0.4836 |
| Dividend Per Share () | 0.0789 | 0.0908 | -13.1 | 0.0000 |
| Announcement Date | 2025-08-26 | 2024-08-29 | NA | 2023-08-31 |
* Annualised
Last Update Time: 2025-09-07 21:40:27
